Background: Many noninvasive tests exist to determine whether patients shou
ld undergo coronary angiography. The routine use of coronary angiography wi
thout previous noninvasive testing is typically not advocated.
Objective: To determine the cost-effectiveness of diagnostic strategies for
patients with chest pain.
Design: Cost-effectiveness analysis,
Data Sources: Published data.
Target Population: Patients who present with chest pain, have no history of
myocardial infarction, and are able to perform an exercise stress test.
Time Horizon: Lifetime.
Perspective: Societal.
Interventions: No testing, exercise electrocardiography, exercise echocardi
ography, exercise single-photon emission computed tomography (SPECT), and c
oronary angiography alone.
Outcome Measures: quality-adjusted life expectancy, lifetime cost, and incr
emental cost-effectiveness.
Results of Base-Case Analysis: The incremental cost-effectiveness ratio of
routine coronary angiography compared with exercise echocardiography was $3
6 400 per quality-adjusted life-year (QALY) saved for 55-year-old men with
typical angina. For 55-year-old men with atypical angina, exercise echocard
iography compared with exercise electrocardiography cost $41 900 per QALY s
aved. If adequate exercise echocardiography was not available, exercise SPE
CT cost $54 800 per QALY saved compared with exercise electrocardiography f
or these patients. For 55-year-old men with nonspecific chest pain, the inc
remental cost-effectiveness ratio of exercise electrocardiography compared
with no testing was $57 700 per QALY saved.
Results of Sensitivity Analysis: On the basis of a probabilistic sensitivit
y analysis, there is a 75% chance that exercise echocardiography costs less
than $50 900 per QALY saved for 55-year-old men with atypical angina.
Conclusions: Exercise electrocardiography or exercise echocardiography resu
lted in reasonable cost-effectiveness ratios for patients at mild to modera
te risk for coronary artery disease in terms of age, sex, and type of chest
pain. Coronary angiography without previous noninvasive testing resulted i
n reasonable cost-effectiveness ratios for patients with a high pretest pro
bability of coronary artery disease.